期刊文献+

糖基化终末产物对3T3-L1脂肪细胞脂联素分泌的影响 被引量:2

EFFECT OF ADVANCED GLYCATION END PRODUCTS ON THE EXPRESSION OF ADIPONECTIN IN 3T3-L1 ADIPOCYTES
下载PDF
导出
摘要 目的糖基化终末产物(Advanced glycation end products,AGE)对3T3-L1脂肪细胞脂联素(adiponectin,APN)分泌的影响。方法3T3-L1小鼠前脂肪细胞体外培养并诱导分化为成熟的脂肪细胞,以PBS和BSA作为阴性对照,用含不同浓度梯度(50μg/ml、100μg/ml、150μg/ml)AGE的培养液对成熟的脂肪细胞体外培养48h,收集细胞和上清液,用RT-PCR方法检测脂联素mRNA的表达,ELISA方法检测培养液中脂联素蛋白的分泌情况。结果AGE干预组脂联素的表达在mRNA和蛋白水平较对照组均明显下降(P<0.05),并且随着AGE浓度的升高脂联素的合成和分泌逐渐减少,其中100μg/ml、150μg/ml AGE干预组脂联素的减少较对照组有显著差异(P<0.001)。结论糖基化终末产物能够通过抑制3T3-L1细胞脂联素mRNA的合成,近而抑制脂联素的分泌,且这种抑制呈浓度依赖性。 Objective To explore the effect of advanced glycation end products on the expression of adiponectin in mouse adipocytes. Methods 3T3-L1 adipocytes were cultured and differentiated in vitro into mature adipocytes. These cells were incubated for 48 hours in the presence of 50μg/ml, 100μg/ml or 150μg/ml AGE-BSA, followed by assay for adiponectin synthesis and secretion. We established 2 control groups with unmodified BSA and phosphate-buffered saline (PBS). Adiponectin mRNA was quantitated by RT-PCR, while adiponectin concentrations in the culture medium were determined by ELISA. Results Adiponectin expression of differentiated adipocytes incubated with AGE-BSA was inhibited significantly as compared with that of the control groups (P〈0. 05). Along with the increasing AGE concentration, adiponectin expression was gradually decreasing. There were significant differences between the 100μg/ml or 150μg/ml AGE experimental groups and the control groups (P〈0. 001). Conclusion These results clarify that AGE-BSA is able to inhibit adiponectin synthesis at a mRNA level, leading to reduction in adiponectin secretion from these adipocytes, and this inhibition is dose-dependent.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2007年第3期270-273,共4页 Chinese Journal of Histochemistry and Cytochemistry
关键词 糖基化终末产物 脂肪细胞 脂联素 Advanced glycation end products Adipocyte Adiponectin
  • 相关文献

参考文献8

  • 1Arita Y,Kihara S,Ouchi N,et al.Paradoxical decrease of an adipose-specific protein,adiponectin,in obesity.Biochem Biophys Res Commun,1999,257:79-83
  • 2Hou FF,Boyce J,Chertow GM,et al.Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin.J Am Soc Nephrol,1998,9:277-283
  • 3Matsuda M,Shimomura I,Sata M,et al.Role of adiponectin in preventing vascular stenosis.J Biol Chem,2002,277:37487-37491
  • 4Kubota N,Terauchi Y,Yamauchi T,et al.Disruption of adiponectin causes insulin resistance and neointimal formation.J Biol Chem,2002,277:25863-25866
  • 5Engeli S,Feldpausch M,Girzekbeak K,et al.Association between adiponectin and mediators of inflammation in obease woman.Diabetes,2003,52:942-947
  • 6Maeda N,Takahashi M,Funahashi T,et al.PPAR-gamma ligands increase expression and plasma concentrations of adiponectin,an adipose2 derived protein.Diabetes,2001,50:2094-2099
  • 7Fasshauer M,Klein J,Neumann S,et al.Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.Biochem Biolphys Res Commun,2002,290:1084-1089
  • 8Ohgami N,Miyazaki A,Sakai M,et al.Advanced glycation end products (AGE) inhibit scavenger receptor class B type Ⅰ mediated reverse cholesterol transport:a new crossroad of AGE to cholesterol metabolism.J Atheroscler Thromb,2003,10:1-6

同被引文献46

  • 1郑智华,马祖等,张涤华,沈清瑞,余学清.血液透析患者营养状态与生存质量关系研究[J].中国血液净化,2005,4(4):187-190. 被引量:113
  • 2俞赞喆,倪兆慧,顾乐怡,朱彩霞,李萍,林爱武,方炜,庞慧华,曹励欧,钱家麒.腹膜透析患者血脂联素与动脉粥样硬化性疾病的关系[J].中华肾脏病杂志,2005,21(12):703-706. 被引量:9
  • 3崔克勤.脂联素研究进展[J].中国医师进修杂志,2006,29(4):71-72. 被引量:6
  • 4李巍,李爱民.脂联素在动脉粥样硬化中的作用研究进展[J].西部医学,2007,19(3):482-485. 被引量:4
  • 5吴红卫,郑景晨.脂联素与糖脂代谢[J].实用全科医学,2007,5(6):541-542. 被引量:10
  • 6Dongfang Gu,Zhigang Wang,Xiaobing Dou,Ximei Zhang,Songtao Li,Lyndsey Vu,Tong Yao,Zhenyuan Song.Inhibition of ERK1/2 pathway suppresses adiponectin secretion via accelerating protein degradation by Ubiquitin–proteasome system: Relevance to obesity-related adiponectin decline[J].Metabolism.2013(8)
  • 7Wenqing Wang,Wenjuan Xing,Haifeng Zhang,Mingge Ding,Lei Shang,Wayne Bond Lau,Xiaoming Wang,Rong Li.Reduced high‐molecular‐weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients[J].Clin Endocrinol.2013(4)
  • 8M.T. Villarreal-Molina,B. Antuna-Puente.Adiponectin: Anti-inflammatory and cardioprotective effects[J].Biochimie.2012(10)
  • 9Klaus W Frommer,Andreas Sch?ffler,Christa Büchler,Jürgen Steinmeyer,Markus Rickert,Stefan Rehart,Fabia Brentano,Steffen Gay,Ulf Müller-Ladner,Elena Neumann.Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis?[J].Annals of the Rheumatic Diseases.2012(10)
  • 10Min Ding,Eva M. Rzucidlo,Jennifer C. Davey,Yi Xie,Renjing Liu,Yu Jin,Lindsey Stavola,Kathleen A. Martin.Adiponectin in the Heart and Vascular System[J].Vitamins and Hormones.2012

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部